Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912117 · ClinicalTrials.gov registry record
Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay
A clinical trial, sponsored by Karius.
- Completed
- Registry status
- 57
- Enrollment target
NCT02912117 is a clinical trial that has completed, run by Karius. The registered enrollment target is 57 participants.
The verdict
NCT02912117 has completed, sponsored by Karius.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
Prospective, observational study at Stanford University Hospital comparing the Karius Infectious Disease Diagnostic Sequencing Assay to the Final Microbiologic Diagnosis in Patients with Fever and Neutropenia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02912117
The ClinicalTrials.gov registry entry for NCT02912117 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Karius, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02912117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02912117 about?
NCT02912117 is a clinical study titled "Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay". Prospective, observational study at Stanford University Hospital comparing the Karius Infectious Disease Diagnostic Sequencing Assay to the Final Microbiologic Diagnosis in Patients with Fever and Neutropenia.
What is the current status of trial NCT02912117?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2016-08. Estimated completion is 2018-05.
Who is sponsoring clinical trial NCT02912117?
This trial is sponsored by Karius, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.